Creative Medical Technology Holdings Inc (CELZ)

[monte379]

Yes, that was a goal, to be self sufficient by the end of 2019. But that goal was made when they were seeing interest in about five offices a month, and at that rate the revs could have sustained the company.

All that came to a screeching halt when they added the 100 CaverStem 2.0 patients to the clinical paper as it seemed like almost every office onboarding decided to wait for the clinical paper.

Now that the paper is out, we saw three offices open quickly.

If that trend continues, maybe they will reach that goal this year. So much is unknown in how fast or how big StemSpine will be for generating revs.

IMHO, we will see very soon how fast new offices open. It surely is a critical time for CELZ.